TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 8.76nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 9.36nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 15.6nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 17nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 17.1nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 17.7nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 19nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 20.7nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 21.1nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 21.8nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 23.2nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 26nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 28nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 28.8nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 36.2nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 39nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 41nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 41.9nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 42.4nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 44nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 44nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 46nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 53.1nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 53.8nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 58.3nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 59.2nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 62nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 64.3nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 66nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 79.8nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 80nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 81.6nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 82nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 87.1nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 95.1nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 97nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 101nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 116nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 118nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 123nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 134nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 135nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 136nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 140nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 154nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 160nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 164nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 166nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 172nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300 [1287-1666]/Histone acetyltransferase type B catalytic subunit(Homo sapiens)
Constellation Pharmaceuticals, Inc.
US Patent
Constellation Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 182nMAssay Description:The p300 HAT domain (residues 1287-1666) was expressed and purified with an N-terminal His tag from Escherichia coli cells. The expressed protein was...More data for this Ligand-Target Pair
